-+ 0.00%
-+ 0.00%
-+ 0.00%

ADAR1 Capital Management reports acquisition of $34,571.592 in Mentari Therapeutics common shares

PUBT·11/10/2026 01:19:07
Listen to the news
ADAR1 Capital Management reports acquisition of $34,571.592 in Mentari Therapeutics common shares
  • ADAR1 Capital Management reported purchasing 2,640 Mentari Therapeutics common shares at $13.0953 per share.
  • Indirect beneficial ownership totaled 98,297 common shares following the purchase.
  • Joint reporting owner Daniel Schneeberger, manager of ADAR1 Capital Management, was listed as a 10% owner.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mentari Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001940272-26-000031), on November 09, 2026, and is solely responsible for the information contained therein.